China Cord Blood Corporation operates within the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Cord Blood with three other
health care providers in Asia:
Cordlife Group Limited
sales of 59.96 million Singapore Dollars [US$45.25 million]
of which 99%
MediNet Group Ltd
of Hong Kong
(99.21 million Hong Kong Dollars [US$12.69 million]
Human Health Holdings Ltd
based in Hong Kong
(481.15 million Hong Kong Dollars [US$61.54 million]
of which 66%
was General practice services).
During the year ended March of 2017, sales at
China Cord Blood were 759.98 million Chinese Renmimbi (US$118.12 million).
increase of 14.6%
versus 2016, when the company's sales were 663.00 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Cord Blood
(and since 2012, sales have increased a total of 100%).